Literature DB >> 28413383

Prostate Cancer: How Young is too Young?

Sahil Gupta1, Arjun Gupta2, Ashish K Saini1, Kaustav Majumder3, Kalpana Sinha1, Anurag Chahal1.   

Abstract

Prostate cancer is the most common non-cutaneous malignancy in men. It is generally considered a cancer of the elderly, and the median age of presentation is 68 years. However 10% of new diagnoses in the USA occur in men aged ≤ 55 years. This may be due to more prevalent screening nowadays, and may also reflect the diagnosis of an increasingly recognized but underappreciated entity, i.e. early-onset prostate cancer. Patients with early onset prostate cancer pose unique challenges. Current data suggest that early-onset prostate cancer is a distinct phenotype-from both an etiological and clinical perspective- that deserves further attention. We present a case of a 28-year-old man who presented with lower urinary tract symptoms and was diagnosed with advanced stage prostate cancer.

Entities:  

Keywords:  Prostate; Prostate cancer; Urology

Year:  2016        PMID: 28413383      PMCID: PMC5385860          DOI: 10.1159/000447143

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  14 in total

Review 1.  Management of lymph node-positive prostate cancer: the role of surgery and radiation therapy.

Authors:  Timur Mitin; Michael Blute; Richard Lee; Jason Efstathiou
Journal:  Oncology (Williston Park)       Date:  2013-07       Impact factor: 2.990

2.  Prostatic adenocarcinoma occurring in men under 50 years of age.

Authors:  D E Johnson; J P Lanieri; A G Ayala
Journal:  J Surg Oncol       Date:  1972       Impact factor: 3.454

3.  Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National Survey.

Authors:  R Huben; N Natarajan; E Pontes; C Mettlin; C R Smart; G P Murphy
Journal:  Urology       Date:  1982-12       Impact factor: 2.649

4.  Adenocarcinoma of the prostate in men younger than 40 years of age: diagnosis and treatment with emphasis on radical prostatectomy findings.

Authors:  K M Ruska; A W Partin; J I Epstein; H Kahane
Journal:  Urology       Date:  1999-06       Impact factor: 2.649

5.  Adenocarcinoma of the prostate discovered in 2 young patients following total prostatovesiculectomy for refractory prostatitis.

Authors:  B E Davis; J W Weigel
Journal:  J Urol       Date:  1990-09       Impact factor: 7.450

Review 6.  Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review.

Authors:  M D'Aprile; D Santini; S Di Cosimo; G Gravante; B Vincenzi; S Spoto; S Costantino; C Rabitti; G Tonini
Journal:  Clin Ter       Date:  2000 Sep-Oct

7.  Early onset prostate cancer has a significant genetic component.

Authors:  Ethan M Lange; Claudia A Salinas; Kimberly A Zuhlke; Anna M Ray; Yunfei Wang; Yurong Lu; Lindsey A Ho; Jingchun Luo; Kathleen A Cooney
Journal:  Prostate       Date:  2011-05-02       Impact factor: 4.104

8.  The prognosis of prostatic cancer in the younger man.

Authors:  G S Harrison
Journal:  Br J Urol       Date:  1983-06

9.  Cancer of the prostate. Do younger men have a poorer survival rate?

Authors:  J M Wilson; I W Kemp; G J Stein
Journal:  Br J Urol       Date:  1984-08

10.  Patient age as a prognostic factor in prostate cancer.

Authors:  H Grönberg; J E Damber; H Jonsson; P Lenner
Journal:  J Urol       Date:  1994-09       Impact factor: 7.450

View more
  3 in total

1.  Modeling the synergistic properties of drugs in hormonal treatment for prostate cancer.

Authors:  Trevor Reckell; Kyle Nguyen; Tin Phan; Sharon Crook; Eric J Kostelich; Yang Kuang
Journal:  J Theor Biol       Date:  2021-01-07       Impact factor: 2.691

Review 2.  Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review).

Authors:  Marzena Wyganowska-Świątkowska; Mateusz Tarnowski; Daniel Murtagh; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Int J Mol Med       Date:  2018-11-07       Impact factor: 4.101

3.  Cancer in Lebanon: A Review of Incidence Rates from 2008 to 2015 and Projections Till 2025.

Authors:  Hussein H Khachfe; Zahraa Rahal; Julie Sammouri; Mira Kheil; Hussein Baydoun; Dana Chatila; Hiba Dirawi; Fouad M Fouad
Journal:  South Asian J Cancer       Date:  2020-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.